Widely prescribed anti-diabetes drug pioglitazone and its combinations were banned on June 26 by Governemnt of India. Along with this, painkiller analgin and anti-depressant deanxit(Flupenthixol+ Melitracen) were also banned under Section 26A of the Drugs and Cosmetics Act(1940) by ministry of health and family welfare, India. Pioglitazone's safety : Always a concern Pioglitazone is an anti-diabetic drug, which has unique action on improving insulin resistance by acting on PPAR receptors. Studies have reported pioglitazone causes congestive heart failure due to fluid retention and also bladder cancer. It also causes muscle aches, headache, nausea, vomiting, loss of appetite, pain in the abdomen etc. Three years ago another drug from this family, rosiglitazone was banned in India following a decision taken in European Union. Following the reports of adverse effects, France has discontinued Pioglitazone, but USA and UK allowed restricted use of Pioglitaz...